Postoperative management of patients with pituitary tumors submitted to pituitary surgery. Experience of a Spanish Pituitary Tumor Center of Excellence

There is a lack of evidence on timing, frequency, and duration of postoperative endocrine, radiologic, and ophthalmologic assessments that should be performed after pituitary surgery (PS). However, it is known that careful optimization of treatment and follow-up strategies as well as a multidiscipli...

Full description

Saved in:
Bibliographic Details
Published inEndocrine Vol. 69; no. 1; pp. 5 - 17
Main Authors Araujo-Castro, M., Pascual-Corrales, E., Martínez San Millan, J. S., Rebolleda, G., Pian, H., Ruz-Caracuel, I., De Los Santos Granados, G., Ley Urzaiz, L., Escobar-Morreale, H. F., Rodríguez Berrocal, V.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.07.2020
Springer Nature B.V
Subjects
Brain tumors
Diabetes
Disease management
Endocrinology
Humanities and Social Sciences
Internal Medicine
Medicine
Medicine & Public Health
multidisciplinary
Patients
Pituitary
Review
Science
Surgery
Tumors
Adrenal insufficiency
Pituitary surgery
Hypopituitarism
Pituitary tumors
Glucocorticoid
Diabetes insipidus
Online AccessGet full text

Cover

More Information
Summary:There is a lack of evidence on timing, frequency, and duration of postoperative endocrine, radiologic, and ophthalmologic assessments that should be performed after pituitary surgery (PS). However, it is known that careful optimization of treatment and follow-up strategies as well as a multidisciplinary approach may have a significant impact on long-term outcomes, improving surgical results, minimize complications and facilitate their correct treatment if occurring, and optimize the hormonal, ophthalmological, and radiological reassessment throughout the follow-up. Considering that there are no specific guidelines on the postoperative management of patients with pituitary tumors (PT), we present our protocol for the postoperative management of patients with PT. It has been elaborated by the multidisciplinary team of a Spanish Pituitary Tumor Center of Excellence (PTCE) that includes at least one neurosurgeon, ENT, neuroradiologist, neuro-ophthalmologist, endocrine pathologist and endocrinologist specialized in pituitary diseases. We elaborated this guideline with the aim of sharing our experience with other centers involved in the management of PT thereby facilitating the postoperative management of patients submitted to PS.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1355-008X
1559-0100
DOI:10.1007/s12020-020-02247-y